CRA developed economic analyses to determine damages in a patent infringement case involving a pharmaceutical product used for the treatment of congestive heart failure and skinny labeling by a generic competitor. CRA provided an initial report on economic damages calculating lost profits and reasonable royalties as well as deposition and trial testimony.
Update on the Texas Business Court: July 2025
The Texas Business Court was formed in September 2024 as a specialized court that aims to provide a more efficient and predictable environment for resolving...